Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-03 | Jean-Pierre Bizzari is a Doctor of Medicine and a graduate of the Nice Medical School and a specialist in oncology. |
| 2016-03-23 | Dr. Bizzari provides our Board with over 30 years of clinical oncology and global drug approval strategy expertise. |
| 2017-03-24 | Dr. Bizzari is a Doctor of Medicine and a graduate of the Nice Medical School and a specialist in oncology. |
| 2018-03-22 | Dr. Bizzari is a Doctor of Medicine and a graduate of the Nice Medical School and a specialist in oncology. |
| 2019-03-22 | Dr. Bizzari provides our Board of Directors with over 30 years of clinical oncology and global drug approval strategy expertise. |
| 2020-03-20 | Dr. Bizzari provides our Board of Directors with over 30 years of clinical oncology and global drug approval strategy expertise. He retired from Celgene Corporation having served as Executive Vice President and Global Head of Oncology. |
| 2021-03-26 | Dr. Bizzari is a Doctor of Medicine and a graduate of the Nice Medical School and a specialist in oncology. |
| 2023-03-24 | Dr. Bizzari is a Doctor of Medicine and a graduate of the Nice Medical School and a specialist in oncology. |
| 2024-03-15 | Jean-Pierre Bizzari, M.D. is listed as a director with no indication of software-related skills. |
Data sourced from SEC filings. Last updated: 2026-02-03